Ritlecitinib (Litfulo™) For Alopecia Areata: Benefits, Risks, & Hair Growth Outcomes
In a recent milestone, a drug called ritlecitinib (brand name Litfulo™) has been approved for treating alopecia areata (AA) in adolescents and adults. Ritlecitinib is a type of drug classified as a kinase inhibitor.[1]Pfizer, (2023), FDA Approves Pfizer’s LITFULO™ (Ritlecitinib) for Adults and Adolescents with Severe Alopecia Areata. Pfizer. Available at: … Continue reading In this … Read more…